Assessment of Two New Electronic Cigarettes in Cigarette Smokers

Sponsor
Virginia Commonwealth University (Other)
Overall Status
Completed
CT.gov ID
NCT03435562
Collaborator
(none)
22
1
1
17.4
1.3

Study Details

Study Description

Brief Summary

The purpose of this study is to determine differences in nicotine delivery, user behavior, subjective effects, and physiological effects, when cigarette smokers use an two new electronic cigarette devices (JUUL and IQOS) relative to their using their own brand of cigarettes.

Condition or Disease Intervention/Treatment Phase
  • Other: JUUL electronic cigarette
  • Other: IQOS electronic cigarette
  • Other: Own Brand cigarette
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
22 participants
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Assessment of Two New Electronic Cigarettes in Cigarette Smokers
Actual Study Start Date :
Mar 3, 2018
Actual Primary Completion Date :
Aug 16, 2019
Actual Study Completion Date :
Aug 16, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: electronic cigarette vs own brand use

Participants will come in for three session. During one session, participants will first complete a 10-puff product use bout with JUUL, and then a 90-minute ad lib product use bout with JUUL (the session will be approximately 3 hours). During one session, participants will first complete a 10-puff product use bout with IQOS, and then a 90-minute ad lib product use bout with IQOS (the session will be approximately 3 hours). During one session, participants will first complete a 10-puff product use bout with their own brand cigarettes, and then a 90-minute ad lib product use bout with their own brand cigarette (the session will be approximately 3 hours). The order of the sessions will be determined randomly and data about session will not be recorded or used in the analysis.

Other: JUUL electronic cigarette
Effects of JUUL electronic cigarette use.

Other: IQOS electronic cigarette
Effects of IQOS electronic cigarette use.

Other: Own Brand cigarette
Effects of own brand cigarette use.

Outcome Measures

Primary Outcome Measures

  1. Change in Plasma Nicotine [Blood will be taken 4 times in each session: at baseline, 5 min after the start of a 10-puff product use, and then before and after an approximately 1-hour ad lib use period.]

    Change in plasma nicotine level

Secondary Outcome Measures

  1. Carbon Monoxide Levels [Carbon monoxide levels will be assessed before and after product use in each approximately 4-hr session: at baseline, 5 min after the end of a 10-puff product use, and then before and after an approximately 1-hour ad lib use period.]

    Carbon monoxide levels (in parts per mission)

  2. Tiffany-Drobes Questionnaire of Smoking Urges - Factor 1 [Questionnaire will be administered 4 times in each each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.]

    This scale is used to assess the extent to which product use reduces the intention to smoke a cigarette, and consists of 5 items that are scored 0 - 7, in which participants clicked seven discrete ratings from 'not at all' to 'extremely'. The items are summed and scores range from 0 to 30 with higher scores indicating higher craving for a cigarette.

  3. Tiffany-Drobes Questionnaire of Smoking Urges - Factor 2 [Questionnaire will be administered 4 times in each each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.]

    This scale is used to assess the extent to which product use reduces the intention to smoke a cigarette, and consists of 4 items that are scored 0 - 7, in which participants clicked seven discrete ratings from 'not at all' to 'extremely'. The items are summed and scores range from 0 to 24 with higher scores indicating higher craving for a cigarette.

  4. Hughes-Hatsukami Questionnaire - Anxious [Questionnaire will be administered 4 times in each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.]

    This scale is used to assess the extent to which product use affects on anxiety and consists of 1 item scored 0 - 100 with 0 being not at all and 100 being extremely.

  5. Hughes-Hatsukami Questionnaire - Craving [Questionnaire will be administered 4 times in each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.]

    This scale is used to assess the extent to which product use affects on craving a cigarette and consists of 1 item scored 0 - 100 with 0 being not at all and 100 being extremely.

  6. Hughes-Hatsukami Questionnaire - Depression [Questionnaire will be administered 4 times in each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.]

    This scale is used to assess the extent to which product use affects on depression and consists of 1 item scored 0 - 100 with 0 being not at all and 100 being extremely.

  7. Hughes-Hatsukami Questionnaire - Difficulty Concentrating [Questionnaire will be administered 4 times in each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.]

    This scale is used to assess the extent to which product use affects having difficulty concentrating and consists of 1 item scored 0 - 100 with 0 being not at all and 100 being extremely.

  8. Hughes-Hatsukami Questionnaire - Drowsy [Questionnaire will be administered 4 times in each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.]

    This scale is used to assess the extent to which product use affects feeling drowsy and consists of 1 item scored 0 - 100 with 0 being not at all and 100 being extremely.

  9. Hughes-Hatsukami Questionnaire - Hunger [Questionnaire will be administered 4 times in each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.]

    This scale is used to assess the extent to which product use affects reducing hunger and consists of 1 item scored 0 - 100 with 0 being not at all and 100 being extremely.

  10. Hughes-Hatsukami Questionnaire - Impatient [Questionnaire will be administered 4 times in each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.]

    This scale is used to assess the extent to which product use affects feeling impatient and consists of 1 item scored 0 - 100 with 0 being not at all and 100 being extremely.

  11. Hughes-Hatsukami Questionnaire - Irritable [Questionnaire will be administered 4 times in each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.]

    This scale is used to assess the extent to which product use affects feeling irritable and consists of 1 item scored 0 - 100 with 0 being not at all and 100 being extremely.

  12. Hughes-Hatsukami Questionnaire - Restless [Questionnaire will be administered 4 times in each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.]

    This scale is used to assess the extent to which product use affects feeling restless and consists of 1 item scored 0 - 100 with 0 being not at all and 100 being extremely.

  13. Hughes-Hatsukami Questionnaire - Desire for Sweets [Questionnaire will be administered 4 times in each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.]

    This scale is used to assess the extent to which product use affects having desire for sweets and consists of 1 item scored 0 - 100 with 0 being not at all and 100 being extremely.

  14. Hughes-Hatsukami Questionnaire - Urge to Smoke [Questionnaire will be administered 4 times in each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.]

    This scale is used to assess the extent to which product use affects having the urge to smoke and consists of 1 item scored 0 - 100 with 0 being not at all and 100 being extremely.

  15. Direct Effects of Nicotine Questionnaire - Awake [Questionnaire will be administered 4 times in each each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.]

    One question is used to assess how much product use makes participants feel awake, and is scored 0 (not at all) to 100 (extremely).

  16. Direct Effects of Nicotine Questionnaire - Calm [Questionnaire will be administered 4 times in each each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.]

    One question is used to assess how much product use makes participants feel calm, and is scored 0 (not at all) to 100 (extremely).

  17. Direct Effects of Nicotine Questionnaire - Concentrate [Questionnaire will be administered 4 times in each each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.]

    One question is used to assess how much product use helps participants concentrate, and is scored 0 (not at all) to 100 (extremely).

  18. Direct Effects of Nicotine Questionnaire - Dizzy [Questionnaire will be administered 4 times in each each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.]

    One question is used to assess how much product use makes participants feel dizzy, and is scored 0 (not at all) to 100 (extremely).

  19. Direct Effects of Nicotine Questionnaire - Reduce Hunger [Questionnaire will be administered 4 times in each each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.]

    One question is used to assess how much product use reduces feeling of hunger, and is scored 0 (not at all) to 100 (extremely).

  20. Direct Effects of Nicotine Questionnaire - Sick [Questionnaire will be administered 4 times in each each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.]

    One question is used to assess how much product use makes participants feel sick, and is scored 0 (not at all) to 100 (extremely).

  21. Direct Effects of Product Use Questionnaire - Pleasant [Questionnaire will be administered 2 times in each each approximately 4-hr session: 10 minutes after the start of a 10-puff use bout, and then after an approxiamtely 1-hour ad lib use period.]

    A single question is used to assess if product use felt pleasant, and is scored 0 (not at all) to 100 (extremely).

  22. Direct Effects of Product Use Questionnaire - Taste Good [Questionnaire will be administered 2 times in each each approximately 4-hr session: 10 minutes after the start of a 10-puff use bout, and then after an approxiamtely 1-hour ad lib use period.]

    A single question is used to assess if product use tasted good, and is scored 0 (not at all) to 100 (extremely).

  23. Direct Effects of Product Use Questionnaire - Satisfying [Questionnaire will be administered 2 times in each each approximately 4-hr session: 10 minutes after the start of a 10-puff use bout, and then after an approxiamtely 1-hour ad lib use period.]

    A single question is used to assess if product use felt satisfying, and is scored 0 (not at all) to 100 (extremely).

  24. Direct Effects of Product Use Questionnaire - Smoke Right Now [Questionnaire will be administered 2 times in each each approximately 4-hr session: 10 minutes after the start of a 10-puff use bout, and then after an approxiamtely 1-hour ad lib use period.]

    A single question is used to assess if product use made them want to use the product again right now, and is scored 0 (not at all) to 100 (extremely).

Other Outcome Measures

  1. Heart Rate [Heat rate will be measured from baseline continuously throughout each each approximately 4-hr session]

    Change in heart rate, measured in beats per minute

  2. Blood Pressure [Blood pressure will be measured from baseline continuously throughout each approximately 4-hr session]

    Change in blood pressure, measured in mm/hg

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 55 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria--participants must be:
  • healthy (determined by self-report)

  • between the ages of 18-55

  • willing to provide informed consent

  • able to attend the lab and abstain from tobacco/nicotine as required and must agree to use designated products according to study protocol

  • cigarette smokers

Exclusion Criteria:
  • Women if they are breast-feeding or test positive for pregnancy (by urinalysis) at screening.

  • Individuals who weigh less than 110 pounds

Some study details about the eligibility criteria are purposely omitted at this time to preserve scientific integrity. Full details will be posted at the conclusion of the study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Clinical Behavioral Pharmacolgy Laboratory Richmond Virginia United States 23298

Sponsors and Collaborators

  • Virginia Commonwealth University

Investigators

  • Principal Investigator: Alison Breland, PhD, Virginia Commonwealth University

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Virginia Commonwealth University
ClinicalTrials.gov Identifier:
NCT03435562
Other Study ID Numbers:
  • HM20012013
First Posted:
Feb 19, 2018
Last Update Posted:
Aug 3, 2020
Last Verified:
Jul 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title Electronic Cigarette vs Own Brand Use
Arm/Group Description Participants will come in for three session. During one session, participants will first complete a 10-puff product use bout with JUUL, and then a 90-minute ad lib product use bout with JUUL (the session will be approximately 3 hours). During one session, participants will first complete a 10-puff product use bout with IQOS, and then a 90-minute ad lib product use bout with IQOS (the session will be approximately 3 hours). During one session, participants will first complete a 10-puff product use bout with their own brand cigarettes, and then a 90-minute ad lib product use bout with their own brand cigarette (the session will be approximately 3 hours). The order of the sessions will be determined randomly and data about session will not be recorded or used in the analysis.
Period Title: Overall Study
STARTED 22
COMPLETED 18
NOT COMPLETED 4

Baseline Characteristics

Arm/Group Title Electronic Cigarette vs Own Brand Use
Arm/Group Description Participants will come in for three session. During one session, participants will first complete a 10-puff product use bout with JUUL, and then a 90-minute ad lib product use bout with JUUL (the session will be approximately 3 hours). During one session, participants will first complete a 10-puff product use bout with IQOS, and then a 90-minute ad lib product use bout with IQOS (the session will be approximately 3 hours). During one session, participants will first complete a 10-puff product use bout with their own brand cigarettes, and then a 90-minute ad lib product use bout with their own brand cigarette (the session will be approximately 3 hours). The order of the sessions will be determined randomly and data about session will not be recorded or used in the analysis.
Overall Participants 18
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
36.8
(9.3)
Sex: Female, Male (Count of Participants)
Female
5
27.8%
Male
13
72.2%
Ethnicity (NIH/OMB) (Count of Participants)
Hispanic or Latino
1
5.6%
Not Hispanic or Latino
15
83.3%
Unknown or Not Reported
2
11.1%
Race (NIH/OMB) (Count of Participants)
American Indian or Alaska Native
0
0%
Asian
0
0%
Native Hawaiian or Other Pacific Islander
0
0%
Black or African American
7
38.9%
White
8
44.4%
More than one race
2
11.1%
Unknown or Not Reported
1
5.6%

Outcome Measures

1. Primary Outcome
Title Change in Plasma Nicotine
Description Change in plasma nicotine level
Time Frame Blood will be taken 4 times in each session: at baseline, 5 min after the start of a 10-puff product use, and then before and after an approximately 1-hour ad lib use period.

Outcome Measure Data

Analysis Population Description
One participant was missing a sample so data was only available for 17 participants for these analyses.
Arm/Group Title JUUL Electronic Cigarette Use IQOS Electronic Cigarette Use Own Brand Cigarette Use
Arm/Group Description During each session, participants will first complete a 10-puff product use bout with JUUL, and then a 90-minute ad lib product use bout with JUUL (each session will be approximately 3 hours). JUUL electronic cigarette: Effects of JUUL electronic cigarette use. During each session, participants will first complete a 10-puff product use bout with IQOS, and then a 90-minute ad lib product use bout with IQOS (each session will be approximately 3 hours). IQOS electronic cigarette: Effects of IQOS electronic cigarette use. During each session, participants will first complete a 10-puff product use bout with their own brand cigarettes, and then a 90-minute ad lib product use bout with their own brand cigarette (each session will be approximately 3 hours). Own Brand cigarette: Effects of own brand cigarette use.
Measure Participants 17 17 17
Post puff bout
7.62
(4.86)
10.65
(6.20)
18.31
(11.39)
Post ad lib
7.19
(8.32)
5.97
(7.70)
12.23
(9.26)
2. Secondary Outcome
Title Carbon Monoxide Levels
Description Carbon monoxide levels (in parts per mission)
Time Frame Carbon monoxide levels will be assessed before and after product use in each approximately 4-hr session: at baseline, 5 min after the end of a 10-puff product use, and then before and after an approximately 1-hour ad lib use period.

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Own Brand Cigarette Use JUUL Electronic Cigarette Use IQOS Electronic Cigarette Use
Arm/Group Description During each session, participants will first complete a 10-puff product use bout with their own brand cigarettes, and then a 90-minute ad lib product use bout with their own brand cigarette (each session will be approximately 3 hours). Own Brand cigarette: Effects of own brand cigarette use. During each session, participants will first complete a 10-puff product use bout with JUUL, and then a 90-minute ad lib product use bout with JUUL (each session will be approximately 3 hours). JUUL electronic cigarette: Effects of JUUL electronic cigarette use. During each session, participants will first complete a 10-puff product use bout with IQOS, and then a 90-minute ad lib product use bout with IQOS (each session will be approximately 3 hours). IQOS electronic cigarette: Effects of IQOS electronic cigarette use.
Measure Participants 18 18 18
Pre puff bout
5.2
(2.4)
5.5
(2.4)
5.3
(2.0)
Post puff bout
8.7
(2.5)
5.1
(2.3)
4.9
(1.8)
Pre ad lib
8.8
(2.8)
5.3
(2.4)
4.6
(1.8)
Post ad lib
16.6
(7.0)
4.7
(1.9)
4.3
(1.4)
3. Secondary Outcome
Title Tiffany-Drobes Questionnaire of Smoking Urges - Factor 1
Description This scale is used to assess the extent to which product use reduces the intention to smoke a cigarette, and consists of 5 items that are scored 0 - 7, in which participants clicked seven discrete ratings from 'not at all' to 'extremely'. The items are summed and scores range from 0 to 30 with higher scores indicating higher craving for a cigarette.
Time Frame Questionnaire will be administered 4 times in each each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Own Brand Cigarette Use JUUL Electronic Cigarette Use IQOS Electronic Cigarette Use
Arm/Group Description During each session, participants will first complete a 10-puff product use bout with their own brand cigarettes, and then a 90-minute ad lib product use bout with their own brand cigarette (each session will be approximately 3 hours). Own Brand cigarette: Effects of own brand cigarette use. During each session, participants will first complete a 10-puff product use bout with JUUL, and then a 90-minute ad lib product use bout with JUUL (each session will be approximately 3 hours). JUUL electronic cigarette: Effects of JUUL electronic cigarette use. During each session, participants will first complete a 10-puff product use bout with IQOS, and then a 90-minute ad lib product use bout with IQOS (each session will be approximately 3 hours). IQOS electronic cigarette: Effects of IQOS electronic cigarette use.
Measure Participants 18 18 18
Pre puff bout
24.8
(8.2)
24.7
(7.5)
25.1
(8.2)
Post puff bout
13.2
(10.7)
20.1
(9.3)
16.0
(9.3)
Pre ad lib
21.2
(8.9)
21.7
(9.3)
20.4
(8.5)
Post ad lib
11.5
(10.2)
17.8
(10.6)
14.4
(9.7)
4. Secondary Outcome
Title Tiffany-Drobes Questionnaire of Smoking Urges - Factor 2
Description This scale is used to assess the extent to which product use reduces the intention to smoke a cigarette, and consists of 4 items that are scored 0 - 7, in which participants clicked seven discrete ratings from 'not at all' to 'extremely'. The items are summed and scores range from 0 to 24 with higher scores indicating higher craving for a cigarette.
Time Frame Questionnaire will be administered 4 times in each each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Own Brand Cigarette Use JUUL Electronic Cigarette Use IQOS Electronic Cigarette Use
Arm/Group Description During each session, participants will first complete a 10-puff product use bout with their own brand cigarettes, and then a 90-minute ad lib product use bout with their own brand cigarette (each session will be approximately 3 hours). Own Brand cigarette: Effects of own brand cigarette use. During each session, participants will first complete a 10-puff product use bout with JUUL, and then a 90-minute ad lib product use bout with JUUL (each session will be approximately 3 hours). JUUL electronic cigarette: Effects of JUUL electronic cigarette use. During each session, participants will first complete a 10-puff product use bout with IQOS, and then a 90-minute ad lib product use bout with IQOS (each session will be approximately 3 hours). IQOS electronic cigarette: Effects of IQOS electronic cigarette use.
Measure Participants 18 18 18
Pre puff bout
11.7
(8.3)
10.3
(8.3)
12.5
(8.4)
Post puff bout
6.9
(7.4)
8.1
(7.8)
6.6
(7.8)
Pre ad lib
9.7
(7.4)
9.5
(7.5)
9.1
(8.6)
Post ad lib
5.5
(7.6)
6.5
(7.2)
6.6
(8.9)
5. Secondary Outcome
Title Hughes-Hatsukami Questionnaire - Anxious
Description This scale is used to assess the extent to which product use affects on anxiety and consists of 1 item scored 0 - 100 with 0 being not at all and 100 being extremely.
Time Frame Questionnaire will be administered 4 times in each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Own Brand Cigarette Use JUUL Electronic Cigarette Use IQOS Electronic Cigarette Use
Arm/Group Description During each session, participants will first complete a 10-puff product use bout with their own brand cigarettes, and then a 90-minute ad lib product use bout with their own brand cigarette (each session will be approximately 3 hours). Own Brand cigarette: Effects of own brand cigarette use. During each session, participants will first complete a 10-puff product use bout with JUUL, and then a 90-minute ad lib product use bout with JUUL (each session will be approximately 3 hours). JUUL electronic cigarette: Effects of JUUL electronic cigarette use. During each session, participants will first complete a 10-puff product use bout with IQOS, and then a 90-minute ad lib product use bout with IQOS (each session will be approximately 3 hours). IQOS electronic cigarette: Effects of IQOS electronic cigarette use.
Measure Participants 18 18 18
Pre puff bout
46.3
(32.5)
42.8
(31.9)
44.5
(34.9)
Post puff bout
24.8
(30.6)
24.4
(31.8)
28.4
(33.9)
Pre ad lib
22.1
(22.8)
20.8
(30.1)
17.2
(27.2)
Post ad lib
19.4
(27.5)
20.4
(27)
28.4
(32.6)
6. Secondary Outcome
Title Hughes-Hatsukami Questionnaire - Craving
Description This scale is used to assess the extent to which product use affects on craving a cigarette and consists of 1 item scored 0 - 100 with 0 being not at all and 100 being extremely.
Time Frame Questionnaire will be administered 4 times in each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Own Brand Cigarette Use JUUL Electronic Cigarette Use IQOS Electronic Cigarette Use
Arm/Group Description During each session, participants will first complete a 10-puff product use bout with their own brand cigarettes, and then a 90-minute ad lib product use bout with their own brand cigarette (each session will be approximately 3 hours). Own Brand cigarette: Effects of own brand cigarette use. During each session, participants will first complete a 10-puff product use bout with JUUL, and then a 90-minute ad lib product use bout with JUUL (each session will be approximately 3 hours). JUUL electronic cigarette: Effects of JUUL electronic cigarette use. During each session, participants will first complete a 10-puff product use bout with IQOS, and then a 90-minute ad lib product use bout with IQOS (each session will be approximately 3 hours). IQOS electronic cigarette: Effects of IQOS electronic cigarette use.
Measure Participants 18 18 18
Pre puff bout
75.2
(30.7)
70.5
(30.9)
73.5
(33.5)
Post puff bout
34.9
(35)
49.3
(36.0)
42.9
(31.8)
Pre ad lib
55.2
(30.5)
54.0
(38)
53.8
(29.9)
Post ad lib
25.5
(29.2)
53.9
(34.9)
36.2
(32.1)
7. Secondary Outcome
Title Hughes-Hatsukami Questionnaire - Depression
Description This scale is used to assess the extent to which product use affects on depression and consists of 1 item scored 0 - 100 with 0 being not at all and 100 being extremely.
Time Frame Questionnaire will be administered 4 times in each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Own Brand Cigarette Use JUUL Electronic Cigarette Use IQOS Electronic Cigarette Use
Arm/Group Description During each session, participants will first complete a 10-puff product use bout with their own brand cigarettes, and then a 90-minute ad lib product use bout with their own brand cigarette (each session will be approximately 3 hours). Own Brand cigarette: Effects of own brand cigarette use. During each session, participants will first complete a 10-puff product use bout with JUUL, and then a 90-minute ad lib product use bout with JUUL (each session will be approximately 3 hours). JUUL electronic cigarette: Effects of JUUL electronic cigarette use. During each session, participants will first complete a 10-puff product use bout with IQOS, and then a 90-minute ad lib product use bout with IQOS (each session will be approximately 3 hours). IQOS electronic cigarette: Effects of IQOS electronic cigarette use.
Measure Participants 18 18 18
Pre puff bout
21.4
(28.3)
15.1
(20.9)
20.5
(26.1)
Post puff bout
9.8
(16.8)
8.8
(16.6)
15.1
(22.6)
Pre ad lib
11.5
(21.5)
8.1
(17.0)
10.6
(20.1)
Post ad lib
8.8
(13.6)
8.2
(16.3)
11.5
(21.7)
8. Secondary Outcome
Title Hughes-Hatsukami Questionnaire - Difficulty Concentrating
Description This scale is used to assess the extent to which product use affects having difficulty concentrating and consists of 1 item scored 0 - 100 with 0 being not at all and 100 being extremely.
Time Frame Questionnaire will be administered 4 times in each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Own Brand Cigarette Use JUUL Electronic Cigarette Use IQOS Electronic Cigarette Use
Arm/Group Description During each session, participants will first complete a 10-puff product use bout with their own brand cigarettes, and then a 90-minute ad lib product use bout with their own brand cigarette (each session will be approximately 3 hours). Own Brand cigarette: Effects of own brand cigarette use. During each session, participants will first complete a 10-puff product use bout with JUUL, and then a 90-minute ad lib product use bout with JUUL (each session will be approximately 3 hours). JUUL electronic cigarette: Effects of JUUL electronic cigarette use. During each session, participants will first complete a 10-puff product use bout with IQOS, and then a 90-minute ad lib product use bout with IQOS (each session will be approximately 3 hours). IQOS electronic cigarette: Effects of IQOS electronic cigarette use.
Measure Participants 18 18 18
Pre puff bout
28.2
(26.4)
37.6
(30.1)
30.0
(31.9)
Post puff bout
18.5
(20.4)
17.3
(19.9)
24.4
(29.9)
Pre ad lib
18.1
(20.8)
15.5
(22.5)
16.8
(20.6)
Post ad lib
10.4
(18.1)
17.8
(25.8)
18.9
(27.0)
9. Secondary Outcome
Title Hughes-Hatsukami Questionnaire - Drowsy
Description This scale is used to assess the extent to which product use affects feeling drowsy and consists of 1 item scored 0 - 100 with 0 being not at all and 100 being extremely.
Time Frame Questionnaire will be administered 4 times in each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Own Brand Cigarette Use JUUL Electronic Cigarette Use IQOS Electronic Cigarette Use
Arm/Group Description During each session, participants will first complete a 10-puff product use bout with their own brand cigarettes, and then a 90-minute ad lib product use bout with their own brand cigarette (each session will be approximately 3 hours). Own Brand cigarette: Effects of own brand cigarette use. During each session, participants will first complete a 10-puff product use bout with JUUL, and then a 90-minute ad lib product use bout with JUUL (each session will be approximately 3 hours). JUUL electronic cigarette: Effects of JUUL electronic cigarette use. During each session, participants will first complete a 10-puff product use bout with IQOS, and then a 90-minute ad lib product use bout with IQOS (each session will be approximately 3 hours). IQOS electronic cigarette: Effects of IQOS electronic cigarette use.
Measure Participants 18 18 18
Pre puff bout
35.2
(25)
33.8
(28.2)
31.9
(33.9)
Post puff bout
28.7
(26.1)
21.4
(24.6)
29.4
(26.5)
Pre ad lib
24.9
(24.3)
25.9
(31.1)
23.4
(24.6)
Post ad lib
23.4
(26.9)
25.3
(27.0)
27.4
(29.8)
10. Secondary Outcome
Title Hughes-Hatsukami Questionnaire - Hunger
Description This scale is used to assess the extent to which product use affects reducing hunger and consists of 1 item scored 0 - 100 with 0 being not at all and 100 being extremely.
Time Frame Questionnaire will be administered 4 times in each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Own Brand Cigarette Use JUUL Electronic Cigarette Use IQOS Electronic Cigarette Use
Arm/Group Description During each session, participants will first complete a 10-puff product use bout with their own brand cigarettes, and then a 90-minute ad lib product use bout with their own brand cigarette (each session will be approximately 3 hours). Own Brand cigarette: Effects of own brand cigarette use. During each session, participants will first complete a 10-puff product use bout with JUUL, and then a 90-minute ad lib product use bout with JUUL (each session will be approximately 3 hours). JUUL electronic cigarette: Effects of JUUL electronic cigarette use. During each session, participants will first complete a 10-puff product use bout with IQOS, and then a 90-minute ad lib product use bout with IQOS (each session will be approximately 3 hours). IQOS electronic cigarette: Effects of IQOS electronic cigarette use.
Measure Participants 18 18 18
Pre puff bout
39.9
(22.7)
43.2
(29.8)
43.0
(35.5)
Post puff bout
31.9
(24.4)
35.6
(33.3)
30.2
(25.5)
Pre ad lib
34.8
(25.9)
39.5
(35.9)
37.7
(29.0)
Post ad lib
39.8
(30.7)
58.4
(29.0)
53.2
(31.9)
11. Secondary Outcome
Title Hughes-Hatsukami Questionnaire - Impatient
Description This scale is used to assess the extent to which product use affects feeling impatient and consists of 1 item scored 0 - 100 with 0 being not at all and 100 being extremely.
Time Frame Questionnaire will be administered 4 times in each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Own Brand Cigarette Use JUUL Electronic Cigarette Use IQOS Electronic Cigarette Use
Arm/Group Description During each session, participants will first complete a 10-puff product use bout with their own brand cigarettes, and then a 90-minute ad lib product use bout with their own brand cigarette (each session will be approximately 3 hours). Own Brand cigarette: Effects of own brand cigarette use. During each session, participants will first complete a 10-puff product use bout with JUUL, and then a 90-minute ad lib product use bout with JUUL (each session will be approximately 3 hours). JUUL electronic cigarette: Effects of JUUL electronic cigarette use. During each session, participants will first complete a 10-puff product use bout with IQOS, and then a 90-minute ad lib product use bout with IQOS (each session will be approximately 3 hours). IQOS electronic cigarette: Effects of IQOS electronic cigarette use.
Measure Participants 18 18 18
Pre puff bout
42.1
(28.3)
41.0
(30.6)
51.4
(31.0)
Post puff bout
23.9
(27.3)
25.9
(31.0)
25.1
(30.9)
Pre ad lib
26.9
(29.3)
31.4
(28.9)
29.7
(30.3)
Post ad lib
25.5
(28.2)
31.8
(30.5)
27.2
(27.0)
12. Secondary Outcome
Title Hughes-Hatsukami Questionnaire - Irritable
Description This scale is used to assess the extent to which product use affects feeling irritable and consists of 1 item scored 0 - 100 with 0 being not at all and 100 being extremely.
Time Frame Questionnaire will be administered 4 times in each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Own Brand Cigarette Use JUUL Electronic Cigarette Use IQOS Electronic Cigarette Use
Arm/Group Description During each session, participants will first complete a 10-puff product use bout with their own brand cigarettes, and then a 90-minute ad lib product use bout with their own brand cigarette (each session will be approximately 3 hours). Own Brand cigarette: Effects of own brand cigarette use. During each session, participants will first complete a 10-puff product use bout with JUUL, and then a 90-minute ad lib product use bout with JUUL (each session will be approximately 3 hours). JUUL electronic cigarette: Effects of JUUL electronic cigarette use. During each session, participants will first complete a 10-puff product use bout with IQOS, and then a 90-minute ad lib product use bout with IQOS (each session will be approximately 3 hours). IQOS electronic cigarette: Effects of IQOS electronic cigarette use.
Measure Participants 18 18 18
Pre puff bout
37.4
(31.0)
34.5
(31.1)
38.7
(33.3)
Post puff bout
14.9
(17.2)
18.4
(22.1)
19.8
(26.3)
Pre ad lib
14.1
(16.0)
15.4
(22.3)
16.8
(21.0)
Post ad lib
14.6
(22.0)
15.1
(26.4)
16.8
(24.1)
13. Secondary Outcome
Title Hughes-Hatsukami Questionnaire - Restless
Description This scale is used to assess the extent to which product use affects feeling restless and consists of 1 item scored 0 - 100 with 0 being not at all and 100 being extremely.
Time Frame Questionnaire will be administered 4 times in each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Own Brand Cigarette Use JUUL Electronic Cigarette Use IQOS Electronic Cigarette Use
Arm/Group Description During each session, participants will first complete a 10-puff product use bout with their own brand cigarettes, and then a 90-minute ad lib product use bout with their own brand cigarette (each session will be approximately 3 hours). Own Brand cigarette: Effects of own brand cigarette use. During each session, participants will first complete a 10-puff product use bout with JUUL, and then a 90-minute ad lib product use bout with JUUL (each session will be approximately 3 hours). JUUL electronic cigarette: Effects of JUUL electronic cigarette use. During each session, participants will first complete a 10-puff product use bout with IQOS, and then a 90-minute ad lib product use bout with IQOS (each session will be approximately 3 hours). IQOS electronic cigarette: Effects of IQOS electronic cigarette use.
Measure Participants 18 18 18
Pre puff bout
40.8
(29.4)
30.2
(25.5)
28.9
(31.8)
Post puff bout
19.7
(24.8)
26.9
(25.9)
19.7
(24.6)
Pre ad lib
27.7
(27.2)
17.9
(25.7)
33.4
(31.4)
Post ad lib
21.5
(28.1)
24.7
(27.6)
27.1
(28.4)
14. Secondary Outcome
Title Hughes-Hatsukami Questionnaire - Desire for Sweets
Description This scale is used to assess the extent to which product use affects having desire for sweets and consists of 1 item scored 0 - 100 with 0 being not at all and 100 being extremely.
Time Frame Questionnaire will be administered 4 times in each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Own Brand Cigarette Use JUUL Electronic Cigarette Use IQOS Electronic Cigarette Use
Arm/Group Description During each session, participants will first complete a 10-puff product use bout with their own brand cigarettes, and then a 90-minute ad lib product use bout with their own brand cigarette (each session will be approximately 3 hours). Own Brand cigarette: Effects of own brand cigarette use. During each session, participants will first complete a 10-puff product use bout with JUUL, and then a 90-minute ad lib product use bout with JUUL (each session will be approximately 3 hours). JUUL electronic cigarette: Effects of JUUL electronic cigarette use. During each session, participants will first complete a 10-puff product use bout with IQOS, and then a 90-minute ad lib product use bout with IQOS (each session will be approximately 3 hours). IQOS electronic cigarette: Effects of IQOS electronic cigarette use.
Measure Participants 18 18 18
Pre puff bout
24.2
(30.7)
27.4
(33.3)
24.8
(28.3)
Post puff bout
16.8
(21.4)
20.3
(27.2)
16.4
(25.7)
Pre ad lib
18.8
(25.8)
20.7
(28.1)
23.8
(27.9)
Post ad lib
17.9
(21.3)
17.4
(24.0)
20.5
(27.0)
15. Secondary Outcome
Title Hughes-Hatsukami Questionnaire - Urge to Smoke
Description This scale is used to assess the extent to which product use affects having the urge to smoke and consists of 1 item scored 0 - 100 with 0 being not at all and 100 being extremely.
Time Frame Questionnaire will be administered 4 times in each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Own Brand Cigarette Use JUUL Electronic Cigarette Use IQOS Electronic Cigarette Use
Arm/Group Description During each session, participants will first complete a 10-puff product use bout with their own brand cigarettes, and then a 90-minute ad lib product use bout with their own brand cigarette (each session will be approximately 3 hours). Own Brand cigarette: Effects of own brand cigarette use. During each session, participants will first complete a 10-puff product use bout with JUUL, and then a 90-minute ad lib product use bout with JUUL (each session will be approximately 3 hours). JUUL electronic cigarette: Effects of JUUL electronic cigarette use. During each session, participants will first complete a 10-puff product use bout with IQOS, and then a 90-minute ad lib product use bout with IQOS (each session will be approximately 3 hours). IQOS electronic cigarette: Effects of IQOS electronic cigarette use.
Measure Participants 18 18 18
Pre puff bout
76.5
(25.2)
67.2
(29.9)
74.7
(31.5)
Post puff bout
39.2
(34.8)
48.8
(31.9)
46.2
(29.5)
Pre ad lib
54.4
(27.6)
46.9
(33.3)
56.9
(27.8)
Post ad lib
24.9
(25.7)
50.0
(31.1)
38
(31.8)
16. Secondary Outcome
Title Direct Effects of Nicotine Questionnaire - Awake
Description One question is used to assess how much product use makes participants feel awake, and is scored 0 (not at all) to 100 (extremely).
Time Frame Questionnaire will be administered 4 times in each each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Own Brand Cigarette Use JUUL Electronic Cigarette Use IQOS Electronic Cigarette Use
Arm/Group Description During each session, participants will first complete a 10-puff product use bout with their own brand cigarettes, and then a 90-minute ad lib product use bout with their own brand cigarette (each session will be approximately 3 hours). Own Brand cigarette: Effects of own brand cigarette use. During each session, participants will first complete a 10-puff product use bout with JUUL, and then a 90-minute ad lib product use bout with JUUL (each session will be approximately 3 hours). JUUL electronic cigarette: Effects of JUUL electronic cigarette use. During each session, participants will first complete a 10-puff product use bout with IQOS, and then a 90-minute ad lib product use bout with IQOS (each session will be approximately 3 hours). IQOS electronic cigarette: Effects of IQOS electronic cigarette use.
Measure Participants 18 18 18
Post puff bout
40.9
(31.7)
33.8
(29.9)
36.5
(30.6)
Post ad lib
45.1
(31.3)
28.1
(29.6)
34.5
(27.4)
17. Secondary Outcome
Title Direct Effects of Nicotine Questionnaire - Calm
Description One question is used to assess how much product use makes participants feel calm, and is scored 0 (not at all) to 100 (extremely).
Time Frame Questionnaire will be administered 4 times in each each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Own Brand Cigarette Use JUUL Electronic Cigarette Use IQOS Electronic Cigarette Use
Arm/Group Description During each session, participants will first complete a 10-puff product use bout with their own brand cigarettes, and then a 90-minute ad lib product use bout with their own brand cigarette (each session will be approximately 3 hours). Own Brand cigarette: Effects of own brand cigarette use. During each session, participants will first complete a 10-puff product use bout with JUUL, and then a 90-minute ad lib product use bout with JUUL (each session will be approximately 3 hours). JUUL electronic cigarette: Effects of JUUL electronic cigarette use. During each session, participants will first complete a 10-puff product use bout with IQOS, and then a 90-minute ad lib product use bout with IQOS (each session will be approximately 3 hours). IQOS electronic cigarette: Effects of IQOS electronic cigarette use.
Measure Participants 18 18 18
Post puff bout
60.9
(36)
47.9
(31.9)
54.4
(31.5)
Post ad lib
60.7
(35.3)
46.6
(29.7)
43.2
(34.5)
18. Secondary Outcome
Title Direct Effects of Nicotine Questionnaire - Concentrate
Description One question is used to assess how much product use helps participants concentrate, and is scored 0 (not at all) to 100 (extremely).
Time Frame Questionnaire will be administered 4 times in each each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Own Brand Cigarette Use JUUL Electronic Cigarette Use IQOS Electronic Cigarette Use
Arm/Group Description During each session, participants will first complete a 10-puff product use bout with their own brand cigarettes, and then a 90-minute ad lib product use bout with their own brand cigarette (each session will be approximately 3 hours). Own Brand cigarette: Effects of own brand cigarette use. During each session, participants will first complete a 10-puff product use bout with JUUL, and then a 90-minute ad lib product use bout with JUUL (each session will be approximately 3 hours). JUUL electronic cigarette: Effects of JUUL electronic cigarette use. During each session, participants will first complete a 10-puff product use bout with IQOS, and then a 90-minute ad lib product use bout with IQOS (each session will be approximately 3 hours). IQOS electronic cigarette: Effects of IQOS electronic cigarette use.
Measure Participants 18 18 18
Post puff bout
34.8
(30.8)
24.5
(26.3)
38.5
(33.7)
Post ad lib
42.0
(34.3)
27.5
(26.3)
27.8
(27.1)
19. Secondary Outcome
Title Direct Effects of Nicotine Questionnaire - Dizzy
Description One question is used to assess how much product use makes participants feel dizzy, and is scored 0 (not at all) to 100 (extremely).
Time Frame Questionnaire will be administered 4 times in each each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Own Brand Cigarette Use JUUL Electronic Cigarette Use IQOS Electronic Cigarette Use
Arm/Group Description During each session, participants will first complete a 10-puff product use bout with their own brand cigarettes, and then a 90-minute ad lib product use bout with their own brand cigarette (each session will be approximately 3 hours). Own Brand cigarette: Effects of own brand cigarette use. During each session, participants will first complete a 10-puff product use bout with JUUL, and then a 90-minute ad lib product use bout with JUUL (each session will be approximately 3 hours). JUUL electronic cigarette: Effects of JUUL electronic cigarette use. During each session, participants will first complete a 10-puff product use bout with IQOS, and then a 90-minute ad lib product use bout with IQOS (each session will be approximately 3 hours). IQOS electronic cigarette: Effects of IQOS electronic cigarette use.
Measure Participants 18 18 18
Post puff bout
40.7
(33.4)
33.7
(33.5)
36.4
(33.7)
Post ad lib
30.1
(36.2)
19.4
(27.2)
26.9
(25.8)
20. Secondary Outcome
Title Direct Effects of Nicotine Questionnaire - Reduce Hunger
Description One question is used to assess how much product use reduces feeling of hunger, and is scored 0 (not at all) to 100 (extremely).
Time Frame Questionnaire will be administered 4 times in each each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Own Brand Cigarette Use JUUL Electronic Cigarette Use IQOS Electronic Cigarette Use
Arm/Group Description During each session, participants will first complete a 10-puff product use bout with their own brand cigarettes, and then a 90-minute ad lib product use bout with their own brand cigarette (each session will be approximately 3 hours). Own Brand cigarette: Effects of own brand cigarette use. During each session, participants will first complete a 10-puff product use bout with JUUL, and then a 90-minute ad lib product use bout with JUUL (each session will be approximately 3 hours). JUUL electronic cigarette: Effects of JUUL electronic cigarette use. During each session, participants will first complete a 10-puff product use bout with IQOS, and then a 90-minute ad lib product use bout with IQOS (each session will be approximately 3 hours). IQOS electronic cigarette: Effects of IQOS electronic cigarette use.
Measure Participants 18 18 18
Post puff bout
41.9
(29.9)
35.2
(27.4)
29.2
(28.8)
Post ad lib
33.0
(27.7)
37.1
(31.0)
34.3
(26.1)
21. Secondary Outcome
Title Direct Effects of Nicotine Questionnaire - Sick
Description One question is used to assess how much product use makes participants feel sick, and is scored 0 (not at all) to 100 (extremely).
Time Frame Questionnaire will be administered 4 times in each each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Own Brand Cigarette Use JUUL Electronic Cigarette Use IQOS Electronic Cigarette Use
Arm/Group Description During each session, participants will first complete a 10-puff product use bout with their own brand cigarettes, and then a 90-minute ad lib product use bout with their own brand cigarette (each session will be approximately 3 hours). Own Brand cigarette: Effects of own brand cigarette use. During each session, participants will first complete a 10-puff product use bout with JUUL, and then a 90-minute ad lib product use bout with JUUL (each session will be approximately 3 hours). JUUL electronic cigarette: Effects of JUUL electronic cigarette use. During each session, participants will first complete a 10-puff product use bout with IQOS, and then a 90-minute ad lib product use bout with IQOS (each session will be approximately 3 hours). IQOS electronic cigarette: Effects of IQOS electronic cigarette use.
Measure Participants 18 18 18
Post puff bout
4.1
(7.5)
8.1
(14.2)
9.5
(19.0)
Post ad lib
2.6
(5.2)
7.8
(14.4)
10.5
(16.8)
22. Secondary Outcome
Title Direct Effects of Product Use Questionnaire - Pleasant
Description A single question is used to assess if product use felt pleasant, and is scored 0 (not at all) to 100 (extremely).
Time Frame Questionnaire will be administered 2 times in each each approximately 4-hr session: 10 minutes after the start of a 10-puff use bout, and then after an approxiamtely 1-hour ad lib use period.

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Own Brand Cigarette Use JUUL Electronic Cigarette Use IQOS Electronic Cigarette Use
Arm/Group Description During each session, participants will first complete a 10-puff product use bout with their own brand cigarettes, and then a 90-minute ad lib product use bout with their own brand cigarette (each session will be approximately 3 hours). Own Brand cigarette: Effects of own brand cigarette use. During each session, participants will first complete a 10-puff product use bout with JUUL, and then a 90-minute ad lib product use bout with JUUL (each session will be approximately 3 hours). JUUL electronic cigarette: Effects of JUUL electronic cigarette use. During each session, participants will first complete a 10-puff product use bout with IQOS, and then a 90-minute ad lib product use bout with IQOS (each session will be approximately 3 hours). IQOS electronic cigarette: Effects of IQOS electronic cigarette use.
Measure Participants 18 18 18
Post puff bout
81.4
(29.8)
50.4
(31.6)
58.8
(36.0)
Post ad lib
81.9
(24.9)
50.6
(31.2)
58.9
(34.4)
23. Secondary Outcome
Title Direct Effects of Product Use Questionnaire - Taste Good
Description A single question is used to assess if product use tasted good, and is scored 0 (not at all) to 100 (extremely).
Time Frame Questionnaire will be administered 2 times in each each approximately 4-hr session: 10 minutes after the start of a 10-puff use bout, and then after an approxiamtely 1-hour ad lib use period.

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Own Brand Cigarette Use JUUL Electronic Cigarette Use IQOS Electronic Cigarette Use
Arm/Group Description During each session, participants will first complete a 10-puff product use bout with their own brand cigarettes, and then a 90-minute ad lib product use bout with their own brand cigarette (each session will be approximately 3 hours). Own Brand cigarette: Effects of own brand cigarette use. During each session, participants will first complete a 10-puff product use bout with JUUL, and then a 90-minute ad lib product use bout with JUUL (each session will be approximately 3 hours). JUUL electronic cigarette: Effects of JUUL electronic cigarette use. During each session, participants will first complete a 10-puff product use bout with IQOS, and then a 90-minute ad lib product use bout with IQOS (each session will be approximately 3 hours). IQOS electronic cigarette: Effects of IQOS electronic cigarette use.
Measure Participants 18 18 18
Post puff bout
77.7
(29.5)
50.5
(32.6)
54.6
(36.4)
Post ad lib
74.0
(32.1)
51.2
(30.7)
49.8
(35.7)
24. Secondary Outcome
Title Direct Effects of Product Use Questionnaire - Satisfying
Description A single question is used to assess if product use felt satisfying, and is scored 0 (not at all) to 100 (extremely).
Time Frame Questionnaire will be administered 2 times in each each approximately 4-hr session: 10 minutes after the start of a 10-puff use bout, and then after an approxiamtely 1-hour ad lib use period.

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Own Brand Cigarette Use JUUL Electronic Cigarette Use IQOS Electronic Cigarette Use
Arm/Group Description During each session, participants will first complete a 10-puff product use bout with their own brand cigarettes, and then a 90-minute ad lib product use bout with their own brand cigarette (each session will be approximately 3 hours). Own Brand cigarette: Effects of own brand cigarette use. During each session, participants will first complete a 10-puff product use bout with JUUL, and then a 90-minute ad lib product use bout with JUUL (each session will be approximately 3 hours). JUUL electronic cigarette: Effects of JUUL electronic cigarette use. During each session, participants will first complete a 10-puff product use bout with IQOS, and then a 90-minute ad lib product use bout with IQOS (each session will be approximately 3 hours). IQOS electronic cigarette: Effects of IQOS electronic cigarette use.
Measure Participants 18 18 18
Post puff bout
84.3
(24.4)
47.0
(33.2)
58.8
(30.9)
Post ad lib
83.7
(24.5)
46.5
(31.5)
58.8
(33.3)
25. Secondary Outcome
Title Direct Effects of Product Use Questionnaire - Smoke Right Now
Description A single question is used to assess if product use made them want to use the product again right now, and is scored 0 (not at all) to 100 (extremely).
Time Frame Questionnaire will be administered 2 times in each each approximately 4-hr session: 10 minutes after the start of a 10-puff use bout, and then after an approxiamtely 1-hour ad lib use period.

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Own Brand Cigarette Use JUUL Electronic Cigarette Use IQOS Electronic Cigarette Use
Arm/Group Description During each session, participants will first complete a 10-puff product use bout with their own brand cigarettes, and then a 90-minute ad lib product use bout with their own brand cigarette (each session will be approximately 3 hours). Own Brand cigarette: Effects of own brand cigarette use. During each session, participants will first complete a 10-puff product use bout with JUUL, and then a 90-minute ad lib product use bout with JUUL (each session will be approximately 3 hours). JUUL electronic cigarette: Effects of JUUL electronic cigarette use. During each session, participants will first complete a 10-puff product use bout with IQOS, and then a 90-minute ad lib product use bout with IQOS (each session will be approximately 3 hours). IQOS electronic cigarette: Effects of IQOS electronic cigarette use.
Measure Participants 18 18 18
Post puff bout
62.8
(37.7)
45.4
(32.7)
47.2
(39.1)
Post ad lib
44.1
(37.7)
35.5
(29.1)
37.5
(33.5)
26. Other Pre-specified Outcome
Title Heart Rate
Description Change in heart rate, measured in beats per minute
Time Frame Heat rate will be measured from baseline continuously throughout each each approximately 4-hr session

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title
Arm/Group Description
27. Other Pre-specified Outcome
Title Blood Pressure
Description Change in blood pressure, measured in mm/hg
Time Frame Blood pressure will be measured from baseline continuously throughout each approximately 4-hr session

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title
Arm/Group Description

Adverse Events

Time Frame
Adverse Event Reporting Description This protocol was minimal risk and All-Cause Mortality, Serious, and Other [Not Including Serious] Adverse Events were not monitored/assessed.
Arm/Group Title JUUL Electronic Cigarette Use IQOS Electronic Cigarette Use Own Brand Cigarette Use
Arm/Group Description During each session, participants will first complete a 10-puff product use bout with JUUL, and then a 90-minute ad lib product use bout with JUUL (each session will be approximately 3 hours). JUUL electronic cigarette: Effects of JUUL electronic cigarette use. During each session, participants will first complete a 10-puff product use bout with IQOS, and then a 90-minute ad lib product use bout with IQOS (each session will be approximately 3 hours). IQOS electronic cigarette: Effects of IQOS electronic cigarette use. During each session, participants will first complete a 10-puff product use bout with their own brand cigarettes, and then a 90-minute ad lib product use bout with their own brand cigarette (each session will be approximately 3 hours). Own Brand cigarette: Effects of own brand cigarette use.
All Cause Mortality
JUUL Electronic Cigarette Use IQOS Electronic Cigarette Use Own Brand Cigarette Use
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/0 (NaN) 0/0 (NaN) 0/0 (NaN)
Serious Adverse Events
JUUL Electronic Cigarette Use IQOS Electronic Cigarette Use Own Brand Cigarette Use
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/0 (NaN) 0/0 (NaN) 0/0 (NaN)
Other (Not Including Serious) Adverse Events
JUUL Electronic Cigarette Use IQOS Electronic Cigarette Use Own Brand Cigarette Use
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/0 (NaN) 0/0 (NaN) 0/0 (NaN)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

All Principal Investigators ARE employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Alison Breland
Organization Virginia Commonwealth University
Phone 804 628 2300
Email abbrelan@vcu.edu
Responsible Party:
Virginia Commonwealth University
ClinicalTrials.gov Identifier:
NCT03435562
Other Study ID Numbers:
  • HM20012013
First Posted:
Feb 19, 2018
Last Update Posted:
Aug 3, 2020
Last Verified:
Jul 1, 2020